A cross-scale multimodal framework identifies clinically actionable immunotherapy biomarkers in melanoma through bulk to single-cell and spatial transcriptomics integration - PubMed
3 hours ago
- #immunotherapy
- #melanoma
- #transcriptomics
- A cross-scale multimodal framework identifies clinically actionable immunotherapy biomarkers in melanoma.
- Integration of bulk to single-cell and spatial transcriptomics is used.
- Study focuses on cutaneous melanoma, multi-omics, and prognostic models.
- Ethics approval was not required as informed consent was already obtained.
- Authors declare no competing interests.